Patents by Inventor Claire Rodriguez-Lafrasse

Claire Rodriguez-Lafrasse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON
    Publication number: 20230346971
    Abstract: The present disclosure relates to nanoparticles and the uses thereof in medicine, in particular for the treatment of tumours.
    Type: Application
    Filed: November 19, 2021
    Publication date: November 2, 2023
    Inventors: Olivier TILLEMENT, François LUX, Delphine VERNOS, Claire RODRIGUEZ-LAFRASSE, Thomas BRICHART, Marco NATUZZI, Alain GELOEN, Simon CHAMPAGNE, Matteo MARTINI, Paul ROCCHI
  • Treatment of squamous cell carcinoma with HSP27 antisense oligonucleotides and radiotherapy
    Patent number: 9381209
    Abstract: Squamous cell carcinomas, such as squamous head and neck cancer, are treated with a combination of radio-therapy and a therapeutic agent that reduces the amount of hsp27 in the squamous cancer cells. In specific embodiments, the therapeutic agent that reduces the amount of hsp27 is an antisense oligonucleotide therapeutic agent.
    Type: Grant
    Filed: March 4, 2008
    Date of Patent: July 5, 2016
    Assignee: The University of British Columbia
    Inventors: Claire Rodriguez-Lafrasse, Elie Hadchity
  • COMBINATION OF A TLR3 LIGAND AND A CHEMOTHERAPY AGENT WHICH ACTS ON THE INTRINSIC "APOPTOSIS" PATHWAY IN THE TREATMENT OF CANCER
    Publication number: 20120045523
    Abstract: The present invention relates to a drug comprising separately or together (i) a TLR3 ligand and (ii) a chemotherapeutic agent that acts on the intrinsic apoptotic pathway, for simultaneous or sequential administration in the treatment of cancer, wherein the chemotherapeutic agent is selected from topoisomerase II inhibitors, platinum-derived alkylating agents and PI3 kinase inhibitors.
    Type: Application
    Filed: July 31, 2009
    Publication date: February 23, 2012
    Applicants: UNIVERSITE CLAUDE BERNARD LYON I, HOSPICES CIVILS DE LYON
    Inventors: Serge Lebecque, Charles Dumontet, Yves Pacheco, Claire Rodriguez-Lafrasse, Florent Toscano, Yann Estornes, Francois Virard, Isabelle Coste-Invernizzi, Toufic Renno
  • Treatment of Squamous Cell Carcinoma with HSP27 Antisense Oligonucleotides and Radiotherapy
    Publication number: 20100324115
    Abstract: Squamous cell carcinomas, such as squamous head and neck cancer, are treated with a combination of radio-therapy and a therapeutic agent that reduces the amount of hsp27 in the squamous cancer cells. In specific embodiments, the therapeutic agent that reduces the amount of hsp27 is an antisense oligonucleotide therapeutic agent.
    Type: Application
    Filed: March 4, 2008
    Publication date: December 23, 2010
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Claire Rodriguez-Lafrasse, Elie Hadchity